Real-world Outcomes of Avelumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma in Japan: Long-Term Follow-Up from the J-DART2 Retrospective Study
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY(2025)
Key words
Renal cell carcinoma,Avelumab,Axitinib,Real world,Retrospective,Japan
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined